SHUBHADA SANSGIRY to Infliximab
This is a "connection" page, showing publications SHUBHADA SANSGIRY has written about Infliximab.
Connection Strength
0.036
-
Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260.
Score: 0.036